Catalyst Wire Dossier Catalyst Wire Dossier

Flu-IVIG (Influenza-specific hyperimmune intravenous immunoglobulin)

influenza-specific hyperimmune intravenous immunoglobulin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Flu-IVIG (Influenza-specific hyperimmune intravenous immunoglobulin), covering 2016-08-15 to 2016-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot) [Phase 1]

See pricing